Rejane Silva,
Data & Analytics Manager, Grupo Fleury
Vitor Mori,
Executive Partner, Domains, Gartner
Discover how the application of Artificial Intelligence is revolutionizing the tracking and investigation of various diseases, such as breast cancer, automating the extraction of BIRADS type from mammography reports and identifying patients with overdue exams. Rejane Silva, D&A manager at Grupo Fleury, highlights results with over 71,000 patients monitored, high accuracy in risk classification (99.4%), the return of thousands of patients to follow-up, and significant financial impact. A practical and scalable reference for healthcare organizations seeking to turn data into preventive and personalized actions, improving clinical outcomes and system sustainability.
...
Show More
Show Less